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The present study describes the synthesis and receptor binding affinities of the sul~ydryl-reactive vasopressin analogs deamino[Dab(N~-N-maleoyl- 
/I-alanin e)“]AVP (la) and deamino[Lys(N”-N-maleoyl-/I-alanine)8VP (2a). The analogs were obtained by introducing the sulfhydryl-reactive 
maleoyl-~-alanyl group at the &amino group of Dab’ in deamino[Dab4]AVP (1) and at the E-amino group of Lys’ in deamino[Lys*]VP (2), which 
were synthesized by the solid-phase method. Furthermore, the analog modified at Dab4 was prepared as tritium labeled compound (lb) after 
catalytic iodine tritium exchange at Tyr’ in deamino[Dab4]AVP. The sui~ydryl-reactive vasopressin analogs retained high binding affinity for the 
Vz vasopressin receptor in membranes derived from bovine kidney inner medulla. Apparent dissociation constants Kd of 45 nM (compound la) 
and 15 nM (compound 2a) were determined. Incubation of the ligand receptor complexes at pH 5.5 resulted in dissociation of the sulfhydryl-reactive 
vasopressin analogs from the VZ receptor. No indications of a covalent reaction between analogs la, 2a and lb and sulfhydryl groups in or close 
to the hormone binding site of the V1 receptor were found. 
Vasopressin; Vasopressin VZ receptor: Sulfhydryl reagent 
1. 1 NTRODUCTION 
An effect of sulfhydryl group modification on radioli- 
gand binding has been demonstrated for a wide variety 
of membrane receptors (for review see [l]). One of the 
most widely used sul~yd~l group reagents is N-ethyl- 
maleimide. The reaction is irreversible and under mild 
conditions at neutral pH specific for sul~ydryl groups. 
In several cases, e.g. the D-l dopamine receptor [2] and 
opioid receptors [3,4], NEM-sensitive sulfhydryl groups 
are critical for receptor binding. In the case of the p2- 
adrenergic receptor the substitution of conserved ex- 
tracellular cysteines with alanine, results in a reduced 
affinity of the receptor for its ligands [.5]. 
The neurohypophyseal peptide hormone vasopressin 
stimulates water reabsorption in the mammalian kidney 
collecting tubule and in the amphibian urinary bladder 
(for review see [6]). An earlier study showed that in 
isolated toad bladder NEM inhibits the effect of vaso- 
pressin [7]. Recently Birnbaumer et al. reported the 
cloning of the human V, receptor [S]. The receptor has 
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10 cysteine residues. Further experiments are required 
to identify the determinants for ligand binding. We re- 
cently demonstrated that renal V, vasopressin receptors 
in isolated membranes or intact cells can be inactivated 
by pretreatment with several sulfhydryl reagents, and 
especially with NEM. Vasopressin analogs with agonis- 
tic or antagonistic properties protected against this in- 
activation, probably by inhibiting the reaction of NEM 
with sulfhydryl groups [9]. However, it is not clear 
whether the critical sulfhydryl groups are tocated in the 
ligand binding domain or whether the protective ligands 
can change the receptor conformation in such way that 
sulfhydryl groups, outside the binding site, become less 
accessible to NEM. 
SuI~ydryl-reactive vasopressin analogs could be use- 
ful tools to answer this question. If a critical sulfhydryl 
group is in the binding site of the V2 receptor, then 
sulfhydryl-reactive ligands may bind to it covalently. 
Subsequently, these vasopressin receptor-ligand com- 
plexes could not dissociate and the receptor molecules 
become unable to bind vasopressin. If the critical 
sulfhydryl groups are outside the V, receptor binding 
site, then the sullhydryl-reactive vasopressin analogs 
would fail to block the binding site. After dissociation 
of the analogs, the intact receptor molecule could again 
react with its specific ligands. 
In the present report we demonstrate the synthesis of 
two sul~yd~l-reactive vasopressin analogs. For this 
purpose, we introduced the maleoyl#-alanyl residue in 
vasopressin analogs, either in the side chain of position 
4 or 8. We also synthesized one of the analogs in radio- 
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labeled form. Our results with these analogs suggest 
that the sulfhydryl groups important for ligand binding 
to the V2 receptor are either located outside the binding 
site, or not accessible by sulfhydryl-reactive groups in 
position 4 or 8 of the vasopressin sequence. 
2. MATERIALS AND METHODS 
2.1. Materials and HPLC analysis 
Merrifield resin was purchased from Bio-Rad Laboratories GmbH, 
Miinchen, Germany. BOC amino-protected amino acids were pur- 
chased from BACHEM Biochemica GmbH, Heidelberg, Germany. 
N-Mateoyl-fl-alanine and N-hydroxysuccinimide w re the products of 
Fluka Chemie AG, Buchs, Switzerland. [3H]AVP (20 Ci/mmol) was 
purchased from Amersham, Buckinghamshire, England. All other 
chemicals used were of analytical grade. HPLC retention time deter- 
minations were performed with a Knauer system on a 250 x 4.6 mm 
Lichrosorb 10 RP 18 column with a 22.5 ml linear gradient of 18% to 
72% ACN in 0.09% TFA and a flow rate of 1.5 ml/min. 
2.2. Sd'nthesis 
The parent peptides deamino[Dab~lAVP (1) and deamino[Lys~]VP 
(2) were prepared as described previously [10]. The purity was checked 
with TLC, HPLC, UV spectroscopy and amino acid analysis. HPLC 
retention time was 6.07 rain for 1 and 6.55 rain for 2. The tritium 
labeled peptide deamino[[3,5-:~H]Tyr2,Dab4]AVP was prepared from 
deamino[Dab'*]AVP (i) by catalytic dehalogenation f its diiodo-de- 
rivative, following a procedure described previously [i 1]. Specific ac- 
tivity 32.2 Ci/mmol. The synthesis of N-maleoyl-fl-alanine-N-succin- 
imidyl ester (3) was a modification of the procedure of Keller and 
Rudinger [12]. 170 mg (1 retool) N-maleoyl-fl-alanine was treated in 
5 ml ethyl acetate with 126 mg (1.1 retool) N-hydroxysuccinimide. 
After stirring on ice for 1 h and at room temperature for 5 h, the 
solution was filtered and evaporated to dryness. The crystalline prod- 
uct (240 rag), more than 95% pure, was analyzed by TLC and HPLC. 
R, 5,50 rain, yield: 90%. 
Synthesis of deamino[Dab(N<N-maleoyl-fl-alanine)4]AVP (ia) and 
deamino[Lys(N~-N-maleoyl-fl-alanine)WP(2a) (Fig. l): 2 mg (approx- 
imately 2/tmol) peptide (1 or 2) was dissolved in 100/~1 DMF. By the 
addition of 2/zl N-methylmorpholine, t hep H was adjusted to 7.5-8.0. 
To this solution, 2.66 mg (10 #mol) 3 was added. After reaction for 
2 h at room temperature and overnight on ice, the reaction mixture 
was diluted to 5 ml with 10% ACN in water and purified on a Lichro- 
sorb 10 RP-18 column (250 x 22 mm) and subjected to isocratic elu- 
tion with 28.8% ACN in 0.09% TFA at a flow rate of 5 ml/min. The 
products were analyzed by HPLC, FAB spectroscopy, UV spectros- 
copy, amino acid analysis, and found to be more then 95% pure. R,: 
7.23 rain (la) and 7.11 rain (2a). Yields: 28% (la) and 22% (2a). 1 mM 
water solutions of peptides la and 2a were incubated with 10 mM 
2-mercaptoethanesulfonate for 30 rain at 30 °C and the reaction mix- 
tures were analyzed by HPLC. 
Synthesis of deamino[[3,53H]Tyr2oDab(NG-N-maleoyl-fl-alan - 
ine)4]AVP (1 h): 300 ltl ACN/water solution of 86/lmol deamino[[3,5- 
3H]Tyr2,Dab4]AVP was dried under a nitrogen stream in a I ml Eppen- 
dorfcup. The residual material was dissolved in 50/Jl DMF, and l0 
/11 DMF containing 250 ,ug (1/Jmol) 3 and 9/tl N-methylmorpholine 
was added to the solution. The solution was vortexed for 14 h at room 
temperature prior to drying under a nitrogen stream. The residue was 
dissolved in 13.5% ACN containing 0.09% TFA and purified by 
HPLC on a Lichrosorb 10 RP 18 (250 x 4.6 ram) column with 45 ml 
linear gradient of 13.5% to 67.5% ACN in 0.09% TFA at a flow rate 
of 1.5 mllmin. 500 /Jl fractions were collected and aliquots were 
counted for radioactivity. Fractions 30-34, the peak of the radioactiv- 
ity were combined. The retention time of the radioactive product on 
HPLC was the same as R, of la. The recovery of the radioactivity was 
16%. 
2.3. Membrane preparation and receptor binding assays 
Bovine kidney inner medulla plasma membranes were prepared by 
a two-step centrifugation procedure [13]. The 10,000 xg pellet result- 
ing from this procedure had a specific binding capacity of approxi- 
mately 1.3 pmol [3H]AVP/mg protein. 
Binding tests with plasma membranes were performed by incubat- 
ing membranes (100 ~ug of protein) in 100/tl binding buffer (50 mM 
EPPS pH 8.3 and 5 mM MgClx) containing 10 nM [3H]AVP in the 
presence (non-specific binding) or in the absence (total binding) of 1 
~uM AVP for 30 rain at 30°C. To terminate the binding tests, the 
mixtures were diluted with 5 ml of ice-cold washing buffer (10 mM 
EPPS pH 8.3, 2 mM MgCl2 and 0.1% BSA), immediately filtered 
under vacuum through Whatman GF/F filters, and rinsed twice with 
5 ml ice-cold washing buffer. The filters were placed in counting vials 
with scintillation liquid and analyzed by liquid scintillation spectrom- 
etry. Protein determination was performed by means of a modified 
fluorescamine assay [14]. 
Increasing concentrations of [3H]AVP or lh were used in the pres- 
ence (non-specific binding) or in the absence (total binding) of a 
100-fold excess of AVP to determine the binding affinity. 
The receptor affinity was determined in competition binding exper- 
iments of the unlabeled vasopressin analogs. The binding assay sus- 
pensions contained ifferent concentrations of unlabeled peptide and 
10//M AVP. 
In test for irreversible receptor-ligand complex formation, mem- 
branes (100/~g protein in 100/tl binding buffer) were preincubated 
with the peptide ligands (AVP, 1, 2, la, 2a, or [3H]AVP and lh) for 
30 rain at 30°C. After incubation with the ligand, the membranes were 
collected by centrifugation, and resuspended in 500/~1250 mM ammo- 
niumacetate buffer, plt 5.5, to allow non-covalently bound ligand to 
dissociate from the receptor. Alter 5 rain at 30 °C, these membranes 
(with the exception of membranes pretreated with [3H]AVP or lh) 
were collected by centrifugation, resuspended in binding buffer, and 
binding tests with [3H]AVP were performed. In the case of membranes 
incubated with [~H]AVP or Âh, the pH 5.5 treatment was followed 
directly by filtration through the GF/F filter. 
All assays were performed in duplicate. The experiment was carried 
out twice. Binding curves were fitted to a logistic function with a 
weighted iterative least-squares procedure based on the method of 
steepest descent [15]. The figures and tables relate to representative 
experiments. 
3. RESULTS 
The reactivity of the maleoyl group-containing pep- 
tides was examined with 2-mercaptoethanesulfonate 
[12]. Peptides la and 2a reacted quantitatively with the 
sulfhydryl-containing reagent under the same condi- 
tions (pH, time, temperature) asused in the membrane 
receptor binding tests. In aqueous olution at neutral 
pH and at room temperature, the peptides were stable 
for more then 24 hours. The reactions were monitored 
by HPLC (data not shown). 
The affinities of the new sulfhydryl-reactive non-radi- 
oactive vasopressin analogs (la and 2a) and their parent 
peptides (1 and 2) were tested by competitive binding 
assay on bovine kidney membrane containing V2 recep- 
tors (Fig. 2). The affinity of the radioactive maleoyl 
vasopressin derivative deamino[[3,5-3H]Tyr2,Dab(N6- 
N-maleoyl-fl-alanine)4]AVP (lb) was determined i- 
rectly in a dose-dependent binding assay, using 100-fold 
AVP to determine the non-specific binding (Fig. 3). The 
affinities of the labeled and unlabeled derivative of 
deamino[Dab4]AVP were approximately the same. In 
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Fig. 1. Structures of deamino[Dab(N<N-maleoyl-fl-alanine)4]AVP 
(la, A) and desamino[Lys(N"-N-maleoyl-fl-alanine)SVP (2a, B) 
both reactive analogs introduction of the maleoyl-fl- 
alanyl group reduced the affinity only moderately (2- to 
3-fold) as compared to the parent peptide (Table I). 
The complex of the radioactive sulfhydryl-reactive 
peptide lb with the V 2 receptor dissociated uring incu- 
bation at pH 5.5. After this treatment, he receptors 
were able to bind the specific ligand [3H]AVP (results 
not shown). Analysis of membranes incubated with the 
tritium labelled reactive analog lb by SDS-gel electro- 
phoresis did not reveal a covalent reaction of the analog 
with kidney membrane proteins (data not shown). 
Pretreatment of the V= receptors with saturation con- 
centrations of unlabeled sulfhydryl-reactive p ptides la 
and 2a also resulted in non-covalent acid-labile com- 
plexes. After the pH 5,5 treatment of these complexes, 
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Fig. 2. Relative potencies of sulfhydryl-reactive asopressin analogs 
deamino[Dab(N6-N-maleoyl-fl-alanine)4]AVP la (m) and de- 
amino[Lys(N<N-maleoyl-fl-alanine)WP 2a (e)for inhibiting [3H]AVP 
binding. A fixed concentration of [~H]AVP (10 nM) was incubated 
with the V2 receptor containing bovine kidney membrane in the pres- 
ence of various concentrations of unlabeled peptides. 
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Fig. 3. Dose-dependent binding of deamino[[3,5-3H]Tyr2,Dab(N6-N- 
maleoyl-fl-alanine)4]AVP (lb) to the bovine renal V 2 receptor. The 
results show the concentration of specific binding to the membranes 
in several concentrations of the peptide. 
similar to the complexes between the parent peptides 1 
and 2, AVP and the receptor, were able to bind [3H]AVP 
(Table II). 
4. DISCUSSION 
Our recent results uggest that sulflaydryl groups play 
an important role in the binding of ligands to the renal 
V2 receptor. It was possible to inactivate V2 receptor 
molecules with NEM, a specific sulfhydryl reagent. 
However, it is not clear whir which domain of the V 2 
receptor molecule NEM reacts, i.e. where the critical 
sulfhydryl groups are located. 
Photoreactive analogs of the parent peptides 1and 2, 
modified after UV radiation, bound covalently to renal 
V 2 receptors [10]. There are various chemical possibili- 
ties for binding photoreactive groups to the receptor 
molecules, but they are not clearly defined. 
The new peptides presented in this work could bind 
Table I 
Affinities (K~ values) of vasopressin analogs and their sullhydryl- 
derivatives to the V2 receptors in bovine renal medullary membranes 
(Kd values were determined for binding and competition curves de- 
scribed in section 2) 
Peptide K d (nM) KalKd-AVP 
AVP 1.5 +- 0.3 1 
d[Dab4]AVP (1) 25.0 -+ 4.0 16,7 
d[LysS]VP (2) 4.8 +- 0.8 3.2 
d[Dab(N~-N-maleoyl-fl-alanine)4]AVP (la) 44.5 +_ 7.8 29.6 
d[[3,5-3H]Tyr 2,Dab(Na-N-maleoyl-fl - 
alanine)4]AVP (Ih) 34.5 _+ 4.7 22.6 
d[Lys(N~-N-maleoyl-fl-alanine)WP (2a) 14.9 _+ 2.6 9.9 
d = deamino- 
6t 
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Table II 
Specific [“H]AVP binding to bovine kidney V2 receptors after preincu- 
bation the membrane with vasopressin analogs. Control: binding ca- 
pacity remaining after preincubation with AVP. The differences are 
statistically not significant. Experiments were performed as written in 
section 2. 
Ligand Cont. of Receptor binding 
l&and remaining after 
(nM) pr~incu~dtion 
with l&and 
(% of control) 
AVP 10 lOOk 
d[Dab”]AVP (1) 100 92 It: 8 
d[Lys’]VP (2 30 94511 
d[Dab(Nh-N-maleoyl-/3-alanine)4]AVP 100 84 +I4 
(la) 
d[Lys(N”-N-maleoyl-b-alanine)*VP (2a) 50 
d = deamino- 
82 ?I3 
covalently the Vz receptor if a free sulfhydryl group is 
located in the binding site of the receptor molecule and 
if the reaction of the sulfhydryl with the maleoyl group 
is not sterically inhibited. The sulfhydryl-reactive pep- 
tides might be useful tools to determine wether the crit- 
ical sulfhydryl group is inside or outside the binding site 
of the receptor molecule. 
The maleoyl-peptides used in this study have their 
sul~ydryl-reactive moieties in different positions. Pep- 
tides la and lb carry the maleoyl-j$-alanyl group in 
position 4, inside the 20-membered ring structure of the 
vasopressin molecule containing the 6 N-terminal 
amino acids. Peptide 2a is a peptide containing the 
maleoyl-/?-alanyl group in position 8, in the flexible C- 
terminal tripeptide of the vasopressin molecule. None 
of them reacted covalently with the receptor molecule. 
The receptor-ligand complexes of the V, receptor and 
peptides la, lb and 2a dissociated in acidic buffer, and 
the V, receptor, after this treatment, proved to be capa- 
ble to bind its ligand. Our findings suggest that the 
critical sulfhydryl groups, important for ligand binding, 
are either outside the binding site of the receptor mole- 
cule or inaccessible for the maleoyl residue in position 
4 or 8 of the vasopressin molecule. 
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